NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

水產養殖處理市場:按產品和最終用戶預測(至2025年)-COVID-19的累積影響

Aquaculture Therapeutics Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995387
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
水產養殖處理市場:按產品和最終用戶預測(至2025年)-COVID-19的累積影響 Aquaculture Therapeutics Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 190 Pages
簡介

全球水產養殖處理市場預計將從2020年的1,954.68百萬美元增長到2025年底的2,885.67百萬美元。

COVID-19預計將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。

本報告調查了全球水產養殖處理市場,包括市場機遇和挑戰,增長和製約因素,COVID-19的累積影響,最終用戶/區域市場分析,競爭格局,並提供了諸如主要公司的概況之類的信息。 。

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查期
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決定:調查計劃
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場前景
  • 按產品分列的市場前景
  • 最終用戶的市場前景
  • 區域市場前景
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 生長因子
    • 抑製器
    • 市場機會
    • 挑戰
  • 波特的五種力量分析

第6章按產品劃分的市場

  • 絨毛膜促性腺激素
  • 氟苯尼考
  • 福爾馬林溶液
  • 過氧化氫
  • 土黴素
  • 三辛烷甲磺酸鹽

第7章最終用戶的市場

  • 電子商務
  • 獸醫藥房

第8章美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東/非洲市場

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 衝突情況
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 評估,認可,擴展

第12章公司簡介

  • Alpharma Inc.
  • Blue Ridge Aquaculture
  • Cermaq ASA
  • Cooke Aquaculture
  • Kona Bay Marine Resources
  • Nireus Aquaculture S.A
  • Nutreco Holding N.V.
  • Royal Greenland
  • Sea Watch International Ltd.
  • Seafood Company.
  • Selonda Aquaculture S.A.
  • StarKist Taylor Shellfish Inc.
  • Tassal group Ltd.
  • TriMarine International
  • TunaTech GmbH
  • Unima Group
  • ViAqua Therapeutics Ltd

第13章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-CA17E905E905

The Global Aquaculture Therapeutics Market size was estimated at USD 1,954.68 Million in 2020 and expected to reach USD 2,122.82 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.94% to reach USD 3,267.47 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Aquaculture Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Aquaculture Therapeutics Market was studied across Chorionic Gonadotropin, Florfenicol, Formalin Solution, Hydrogen Peroxide, Oxytetracycline, and Tricaine Methane Sulfonate.

Based on End User, the Aquaculture Therapeutics Market was studied across E Commerce and Veterinary Pharmacies.

Based on Geography, the Aquaculture Therapeutics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Aquaculture Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Aquaculture Therapeutics Market, including Alpharma Inc., Blue Ridge Aquaculture, Cermaq ASA, Cooke Aquaculture, Kona Bay Marine Resources, Nireus Aquaculture S.A, Nutreco Holding N.V., Royal Greenland, Sea Watch International Ltd., Seafood Company., Selonda Aquaculture S.A., StarKist Taylor Shellfish Inc., Tassal group Ltd., TriMarine International, TunaTech GmbH, Unima Group, and ViAqua Therapeutics Ltd.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Aquaculture Therapeutics Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Aquaculture Therapeutics Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Aquaculture Therapeutics Market?
  • 4. What is the competitive strategic window for opportunities in the Global Aquaculture Therapeutics Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Aquaculture Therapeutics Market?
  • 6. What is the market share of the leading vendors in the Global Aquaculture Therapeutics Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Aquaculture Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. End User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aquaculture industry
      • 5.1.1.2. Rising bacterial disease affecting the animals cultured in the aquaculture
      • 5.1.1.3. Growing demand for effective aquaculture therapeutic drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Risks of therapeutics to the aquatics and the consumer
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in aquaculture therapeutics and growing demand for the more effective aquaculture therapeutic drugs
      • 5.1.3.2. Extensive government initiatives to support R&D in aquaculture therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations to approve aquaculture therapeutics
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Aquaculture Therapeutics Market, by Product

  • 6.1. Introduction
  • 6.2. Chorionic Gonadotropin
  • 6.3. Florfenicol
  • 6.4. Formalin Solution
  • 6.5. Hydrogen Peroxide
  • 6.6. Oxytetracycline
  • 6.7. Tricaine Methane Sulfonate

7. Aquaculture Therapeutics Market, by End User

  • 7.1. Introduction
  • 7.2. E Commerce
  • 7.3. Veterinary Pharmacies

8. Americas Aquaculture Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Aquaculture Therapeutics Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Aquaculture Therapeutics Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Alpharma Inc.
  • 12.2. Blue Ridge Aquaculture
  • 12.3. Cermaq ASA
  • 12.4. Cooke Aquaculture
  • 12.5. Kona Bay Marine Resources
  • 12.6. Nireus Aquaculture S.A
  • 12.7. Nutreco Holding N.V.
  • 12.8. Royal Greenland
  • 12.9. Sea Watch International Ltd.
  • 12.10. Seafood Company.
  • 12.11. Selonda Aquaculture S.A.
  • 12.12. StarKist Taylor Shellfish Inc.
  • 12.13. Tassal group Ltd.
  • 12.14. TriMarine International
  • 12.15. TunaTech GmbH
  • 12.16. Unima Group
  • 12.17. ViAqua Therapeutics Ltd

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHORIONIC GONADOTROPIN, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHORIONIC GONADOTROPIN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FLORFENICOL, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FLORFENICOL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FORMALIN SOLUTION, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FORMALIN SOLUTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HYDROGEN PEROXIDE, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HYDROGEN PEROXIDE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OXYTETRACYCLINE, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OXYTETRACYCLINE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TRICAINE METHANE SULFONATE, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TRICAINE METHANE SULFONATE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2026
  • FIGURE 25. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY E COMMERCE, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY E COMMERCE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VETERINARY PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 30. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 32. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. CALIFORNIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. FLORIDA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. ILLINOIS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. NEW YORK AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. OHIO AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. PENNSYLVANIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. TEXAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 45. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 47. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 58. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL AQUACULTURE THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 71. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AQUACULTURE THERAPEUTICS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL AQUACULTURE THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY CHORIONIC GONADOTROPIN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FLORFENICOL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY FORMALIN SOLUTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY HYDROGEN PEROXIDE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY OXYTETRACYCLINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY TRICAINE METHANE SULFONATE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY E COMMERCE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL AQUACULTURE THERAPEUTICS MARKET SIZE, BY VETERINARY PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CANADA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. MEXICO AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. UNITED STATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CALIFORNIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CALIFORNIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. FLORIDA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. FLORIDA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ILLINOIS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ILLINOIS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. NEW YORK AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. NEW YORK AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. OHIO AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. OHIO AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. PENNSYLVANIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. PENNSYLVANIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. TEXAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. TEXAS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ASIA-PACIFIC AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CHINA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDONESIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. JAPAN AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. MALAYSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PHILIPPINES AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. SOUTH KOREA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. THAILAND AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. FRANCE AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. GERMANY AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. ITALY AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. NETHERLANDS AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. QATAR AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. RUSSIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SAUDI ARABIA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH AFRICA AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SPAIN AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED ARAB EMIRATES AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. UNITED KINGDOM AQUACULTURE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SCORES
  • TABLE 86. GLOBAL AQUACULTURE THERAPEUTICS MARKET: BUSINESS STRATEGY
  • TABLE 87. GLOBAL AQUACULTURE THERAPEUTICS MARKET: PRODUCT SATISFACTION
  • TABLE 88. GLOBAL AQUACULTURE THERAPEUTICS MARKET: RANKING
  • TABLE 89. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 90. GLOBAL AQUACULTURE THERAPEUTICS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 91. GLOBAL AQUACULTURE THERAPEUTICS MARKET: MERGER & ACQUISITION
  • TABLE 92. GLOBAL AQUACULTURE THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 93. GLOBAL AQUACULTURE THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 94. GLOBAL AQUACULTURE THERAPEUTICS MARKET: INVESTMENT & FUNDING
  • TABLE 95. GLOBAL AQUACULTURE THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 96. GLOBAL AQUACULTURE THERAPEUTICS MARKET: LICENSE & PRICING
  • TABLE 97. GLOBAL AQUACULTURE THERAPEUTICS MARKET: CONTACT DETAILS